Literature DB >> 20942778

Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways.

Cecilia Götherström1, Andreas Lundqvist, Ida Rasmusson Duprez, Richard Childs, Louise Berg, Katarina le Blanc.   

Abstract

BACKGROUND AIMS: Multipotent mesenchymal stromal cells, also known as mesenchymal stem cells (MSC), can be isolated from adult and fetal tissues. Recently, there has been considerable interest in MSC because they have features favorable for transplantation, namely their multipotency and non-immunogenic properties.
METHODS: We analyzed how human MSC derived from first-trimester fetal liver and adult bone marrow interact with naive and activated innate natural killer (NK) cells. NK cell function was studied by measuring killing of MSC, as well as degranulation (CD107a) induced by MSC. To assess the importance of NK cell killing, expression of surface epitopes was analyzed by flow cytometry on MSC before and after stimulation with interferon (IFN)γ.
RESULTS: Fetal and adult MSC express several ligands to activating NK cell receptors as well as low levels of HLA class I, with large inter-individual variation. Naive peripheral blood NK cells did not lyse fetal or adult MSC, whereas interleukin (IL)2 activated allogeneic as well as autologous NK cells did. Pre-incubation of MSC with IFN-γ increased their levels of HLA class I, protecting them from NK cell recognition. Fetal and adult MSC were preferably killed via the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and Fas ligand (FasL) pathways, respectively. Blocking NKG2D reduced NK cell degranulation in both fetal and adult MSC.
CONCLUSIONS: Fetal and adult MSC differ in their interactions with NK cells. Both fetal and adult MSC are susceptible to lysis by activated NK cells, which may have implications for the use of MSC in cell therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20942778     DOI: 10.3109/14653249.2010.523077

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  33 in total

Review 1.  Multipotent mesenchymal stromal cells and the innate immune system.

Authors:  Katarina Le Blanc; Dimitrios Mougiakakos
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

2.  Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials.

Authors:  Catarina R Almeida; Daniela P Vasconcelos; Raquel M Gonçalves; Mário A Barbosa
Journal:  J R Soc Interface       Date:  2011-07-13       Impact factor: 4.118

3.  Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).

Authors:  O Parolini; F Alviano; A G Betz; D W Bianchi; C Götherström; U Manuelpillai; A L Mellor; R Ofir; P Ponsaerts; S A Scherjon; M L Weiss; S Wolbank; K J Wood; C V Borlongan
Journal:  Placenta       Date:  2011-05-14       Impact factor: 3.481

4.  MSC-based therapies in solid organ transplantation.

Authors:  V Benseler; N Obermajer; C L Johnson; Y Soeder; M D Dahlke; F C Popp
Journal:  Hepatol Int       Date:  2014-01-04       Impact factor: 6.047

Review 5.  Interactions between mesenchymal stem cells and the immune system.

Authors:  Na Li; Jinlian Hua
Journal:  Cell Mol Life Sci       Date:  2017-02-18       Impact factor: 9.261

6.  Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.

Authors:  Cedric Menard; Luciano Pacelli; Giulio Bassi; Joelle Dulong; Francesco Bifari; Isabelle Bezier; Jasmina Zanoncello; Mario Ricciardi; Maelle Latour; Philippe Bourin; Hubert Schrezenmeier; Luc Sensebé; Karin Tarte; Mauro Krampera
Journal:  Stem Cells Dev       Date:  2013-02-25       Impact factor: 3.272

Review 7.  NK and MSCs crosstalk: the sense of immunomodulation and their sensitivity.

Authors:  Javier G Casado; R Tarazona; F M Sanchez-Margallo
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

8.  In Vivo Bioluminescence Imaging of Transplanted Mesenchymal Stromal Cells and Their Rejection Mediated by Intrahepatic NK Cells.

Authors:  Jing-Jing Liu; Xiao-Jun Hu; Zheng-Ran Li; Rong-Hua Yan; Dan Li; Jin Wang; Hong Shan
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

9.  Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture.

Authors:  Mehdi Najar; Mohammad Fayyad-Kazan; Nathalie Meuleman; Dominique Bron; Hussein Fayyad-Kazan; Laurence Lagneaux
Journal:  Mol Cell Biochem       Date:  2018-01-30       Impact factor: 3.396

10.  Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.

Authors:  Mehdi Najar; Mohammad Fayyad-Kazan; Nathalie Meuleman; Dominique Bron; Hussein Fayyad-Kazan; Laurence Lagneaux
Journal:  J Cell Commun Signal       Date:  2018-01-19       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.